Cas:885271-57-8 tert-Butyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate manufacturer & supplier

We serve Chemical Name:tert-Butyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate CAS:885271-57-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-Butyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate

Chemical Name:tert-Butyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate
CAS.NO:885271-57-8
Synonyms:2-Methyl-2-propanyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate;1H-Indazole-1-carboxylic acid, 3-bromo-5-fluoro-, 1,1-dimethylethyl ester;tert-Butyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate;tert-butyl 3-bromo-5-fluoroindazole-1-carboxylate
Molecular Formula:C12H12BrFN2O2
Molecular Weight:315.138
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:380.7±45.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.588
PSA:44.12000
Exact Mass:314.006622
LogP:3.93

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Methyl-2-propanyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 3-bromo-5-fluoroindazole-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Indazole-1-carboxylic acid, 3-bromo-5-fluoro-, 1,1-dimethylethyl ester Use and application,tert-butyl 3-bromo-5-fluoroindazole-1-carboxylate technical grade,usp/ep/jp grade.


Related News: “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. (R)-N,6-dihydroxy-7-methoxy-2-((4-methoxyphenyl)sulfonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide manufacturers Both were randomised, double-blinded, placebo-controlled trials in patients with moderate to severe autoantibody-positive SLE who were receiving standard therapy. L-Methionine,D-alanyl-L-prolyl-L-valyl-L-seryl-L-glutaminyl-L-methionyl-L-arginyl-L-methionyl-L-alanyl-L-threonyl-L-prolyl-L-leucyl-L-leucyl-L-methionyl-L-arginyl-L-prolyl-L-methionyl-L-seryl- suppliers With an up-to-date working knowledge of both established biocatalytic processes and the very latest techniques, a trusted API CDMO provider can offer a suite of technical capabilities, backed by highly trained personnel and a proven track record of consistent quality and regulatory compliance. (4-bromo-3-chlorobut-2-enyl)-tributylphosphanium,bromide vendor & factory.